Viewing Study NCT04201418


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-03-04 @ 3:44 PM
Study NCT ID: NCT04201418
Status: COMPLETED
Last Update Posted: 2022-06-06
First Post: 2019-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation
Sponsor: Alnylam Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALN-TTR02-012
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators